Subscribe

Ratchaphruek Hospital Public Company Limited (RPH.BK)

THB4.98 +0.02 (+0.40%)
TH SET Healthcare Medical - Care Facilities
Address 456, Moo 14, Mittraphap Road 40000
Khon Kaen, TH
CEO Teerawat Srinakarin
Website rph.co.th
IPO 2017-02-27
ISIN TH7757010007

Explore sections of this company profile

Description

Ratchaphruek Hospital Public Company Limited, known as Ratchaphruek Hospital, runs a healthcare facility in Thailand, delivering a comprehensive array of medical services. Its extensive offerings encompass various specialties, including internal medicine (such as dermatology, neurology, hematology, pulmonology, rheumatology, gastroenterology, nephrology, diabetes and endocrine care, and cardiology), a range of surgical procedures (general, urological, and colorectal), and specialized treatments in areas like pediatrics, orthopedics, ear-nose-throat (ENT), ophthalmology, obstetrics and gynecology, preventative health check-ups, dentistry, anesthesiology, emergency care, stroke management, breast health, hearing and balance, rehabilitation, and diagnostic radiology. The hospital also supplies medicines and medical provisions. Incorporated in 1993 in Khon Kaen, Thailand, the company was initially named Sithan Karnpat Company Limited, changing to its current designation in September 2016.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
THB4.98 +0.02 (+0.40%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
127.2K
Beta
-0.03
Float Shares
267.96M
Free Float %
50.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% -0.41% -2.01% -3.37% -1.21% -1.61% -7.05% -19.34% -4.31% +1.67% +1.67%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
4.98
DCF (Unlevered) 24.48 +391.6%
DCF (Levered) 26.11 +424.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 0% Bullish
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 1 0
Quality scores
Altman Z-Score
7.92
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A+
Overall Score
5 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Care Facilities: +10.2%
    +3.3% Q1'26: -5.4% (vs Q1'25)
  • EPS growth Medical - Care Facilities: +19.2%
    +6.3% Q1'26: -31.4% (vs Q1'25)
  • FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +12.3% Q1'26: +6.3% (vs Q1'25)
  • EBIT margin Medical - Care Facilities: +11.3%
    +17.7% Q1'26: +12.8% (vs Q1'25)
  • ROIC Medical - Care Facilities: +6.8%
    +12.1% Q1'26: +7.8% (vs Q1'25)
  • Share dilution Medical - Care Facilities: +0.0%
    -2.3% Q1'26: -1.8% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.01× Q1'26: 0.01× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.04) × ERP
WACC = 100% × Ke + 0% × Kd (15.6%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 24.48 Current price: 4.98
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Revenue
409.80M
est: 410.50M (-0.2%)
413.02M
est: 412.00M (+0.2%)
532.89M
est: 528.00M (+0.9%)
816.58M
est: 813.00M (+0.4%)
799.33M
est: 786.00M (+1.7%)
1.41B
est: 1.19B (+18.5%)
1.33B
est: 1.26B (+5.5%)
1.16B
est: 1.02B (+13.9%)
1.13B
est: 1.06B (+6.1%)
1.16B
est: 1.23B (-5.5%)
EBITDA
102.00M
est: 129.99M (-21.5%)
92.91M
est: 130.47M (-28.8%)
104.58M
est: 167.20M (-37.5%)
217.06M
est: 257.46M (-15.7%)
213.49M
est: 248.91M (-14.2%)
599.02M
est: 377.47M (+58.7%)
457.67M
est: 398.06M (+15.0%)
326.00M
est: 322.69M (+1.0%)
299.54M
est: 331.06M (-9.5%)
285.09M
est: 384.16M (-25.8%)
EBIT
87.40M
est: 97.40M (-10.3%)
80.19M
est: 97.76M (-18.0%)
64.56M
est: 125.28M (-48.5%)
130.32M
est: 192.91M (-32.4%)
124.32M
est: 186.50M (-33.3%)
509.76M
est: 282.84M (+80.2%)
363.75M
est: 298.26M (+22.0%)
235.49M
est: 241.79M (-2.6%)
216.94M
est: 256.09M (-15.3%)
205.80M
est: 297.16M (-30.7%)
Net Income
67.90M
est: 98.27M (-30.9%)
63.04M
est: 60.06M (+5.0%)
48.43M
est: 54.60M (-11.3%)
96.41M
est: 92.81M (+3.9%)
93.84M
est: 72.23M (+29.9%)
402.99M
est: 259.90M (+55.1%)
286.47M
est: 294.82M (-2.8%)
184.45M
est: 114.65M (+60.9%)
172.53M
est: 117.32M (+47.1%)
182.37M
SGA
55.32M
est: 58.26M (-5.0%)
61.08M
est: 58.47M (+4.5%)
91.84M
est: 74.93M (+22.6%)
128.36M
est: 115.38M (+11.2%)
121.58M
est: 111.55M (+9.0%)
167.72M
est: 169.17M (-0.9%)
149.50M
est: 178.39M (-16.2%)
191.46M
est: 144.62M (+32.4%)
181.22M
est: 147.84M (+22.6%)
162.54M
est: 171.55M (-5.3%)
EPS
0.12
est: 0.18 (-33.3%)
0.12
est: 0.11 (+9.1%)
0.09
est: 0.10 (-11.3%)
0.18
est: 0.17 (+5.9%)
0.17
est: 0.13 (+28.5%)
0.74
est: 0.48 (+55.4%)
0.52
est: 0.54 (-3.7%)
0.34
est: 0.21 (+61.9%)
0.32
est: 0.22 (+45.5%)
0.34
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-05-11 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-05-08 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-05-07 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-05-06 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-05-05 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-04-30 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-04-29 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-04-28 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-04-27 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-04-24 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-04-23 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-22 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-21 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-20 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-17 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-16 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
211.68M
OE per share TTM
0.40
Owner's Yield
8.18%
Maintenance CapEx ratio
23.47%
Maint CapEx / Avg PPE
129.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
391.3K
Shares Outstanding
530.41M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Sudhon Sriyapant Chairman of the Board & President 428.4K male
Teerawat Srinakarin Chief Executive Officer & Director 417.0K
Julalak Boonrith Head of Internal Audit female
Sireethorn Palkird Chief Nursing Officer female
Supaporn Sukhee Chief of Accounting & Finance female
Wadcharapron Wiboon Chief Human Resources Officer & Human Resource Director female
Associate Jiraporn Srinakarin Chief Medical Officer
Weerada Thongtranon Chief Information Officer
Chularat Sirisingh Company Secretary & Investor Relations female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits